Private company
venBio Global Strategic Fund II L.P.
Company in the Cayman Islands incorporated in the Cayman Islands. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersE91
Corporate structure
venBio Global Strategic Fund II L.P. sits at the top of its group. 4 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- venBio Global Strategic Fund II L.P. E9
- Akero Therapeutics, Inc. Stake · San Francisco, California, United States
- Checkmate Pharmaceuticals Stake · Cambridge
- Harmony Biosciences Holdings, Inc. Stake · Plymouth Meeting, Pennsylvania
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.
Stakes it holds
venBio Global Strategic Fund II L.P. has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).
- Akero Therapeutics, Inc.SC 13D/A Sep 15, 20222
- Checkmate PharmaceuticalsSC 13G/A May 5, 2022 to Jun 7, 20223
- Harmony Biosciences Holdings, Inc.SC 13G/A Feb 14, 20224
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4